Effects of d-cycloserine on negative symptoms in schizophrenia-Reference-Cited by-同舟云学术

Effects of d-cycloserine on negative symptoms in schizophrenia

Published:2004-12 Issue:2-3 Volume:71 Page:239-248
ISSN:0920-9964
Container-title:Schizophrenia Research
language:en
Short-container-title:Schizophrenia Research

Author:

Duncan Erica J.,Szilagyi Sandor,Schwartz Marion P.,Bugarski-Kirola Dragana,Kunzova Alena,Negi Shobhit,Stephanides Myrsini,Efferen Toby R.,Angrist Burt,Peselow Eric,Corwin June,Gonzenbach Stephen,Rotrosen John P.

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference56 articles.

1. A rating scale for emotional blunting;Abrams;Am. J. Psychiatry,1978

2. The Scale for the Assessment of Negative Symptoms (SANS): conceptualization and theoretical foundation;Andreasen;Br. J. Psychiatry,1989

3. A synaptic model of memory: long-term potentiation in the hippocampus;Bliss;Nature,1993

4. Plasma catecholamine metabolites and early response to haloperidol;Bowers;J. Clin. Psychiatry,1984

5. The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice;Carlsson;J. Neural Transm,1989

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Finding the right dose: NMDAR modulating treatments for cognitive and plasticity deficits in schizophrenia and the role of pharmacodynamic target engagement;Biological Psychiatry;2024-08

2. d-Cycloserine enhances the bidirectional range of NMDAR-dependent hippocampal synaptic plasticity;Translational Psychiatry;2024-01-09

3. NRX-101, a Rapid-Acting Anti-Depressant, Does Not Cause Neurotoxicity Following Ketamine Administration in Preclinical Models;International Journal of Toxicology;2023-05-24

4. The D-amino acid oxidase inhibitor luvadaxistat improves mismatch negativity in patients with schizophrenia in a randomized trial;Neuropsychopharmacology;2023-03-16

5. D-Cycloserine enhances the bidirectional range of NMDAR-dependent hippocampal synaptic plasticity;2022-10-24